Schedule 13D ownership disclosure

TITAN PHARMACEUTICALS INC DE

Security class unavailable · CUSIP: 888314705

Event date: 2024-04-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001829126-24-002251
Form type
SC 13D/A
Filer
Sire Group Ltd.
CIK
CIK 1995392
Filed
Apr 05, 2024
Reporting period
Apr 05, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub